CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Revenue	$ 0	$ 2
Operating expenses:
Research and development	427	347
General and administrative	585	747
Total operating expenses	1,012	1,094
Loss from operations	(1,012)	(1,092)
Other income, net	6	19
Net loss	$ (1,006)	$ (1,073)
Earnings per share, Basic	$ (0.59)	$ (0.67)
Earnings per share, Diluted	$ (0.59)	$ (0.67)
Weighted average common shares outstanding, basic	1,948,357	1,601,252
Weighted average common shares outstanding, diluted	1,948,357	1,601,252